Managing chronic pain patients at the time of COVID-19 pandemic

Minerva Anestesiol. 2020 Aug;86(8):797-799. doi: 10.23736/S0375-9393.20.14666-2. Epub 2020 May 12.

Authors

Flaminia Coluzzi¹, Franco Marinangeli², Joseph Pergolizzi³

Affiliations

¹ Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University, Polo Pontino, Latina, Italy - flaminia.coluzzi@uniroma1.it.
² Department of Anesthesiology, Intensive Care, and Pain Therapy, University of L'Aquila, L'Aquila, Italy.
³ NEMA Research Inc., Naples, FL, USA.

PMID: 32400999
DOI: 10.23736/S0375-9393.20.14666-2

No abstract available

Publication types

Editorial

MeSH terms

Analgesics, Opioid / adverse effects
Analgesics, Opioid / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Betacoronavirus*
COVID-19
Chronic Pain / therapy*
Coronavirus Infections / complications*
Coronavirus Infections / epidemiology
Drug Prescriptions
Home Care Services
Humans
Immune Tolerance / drug effects
Infusion Pumps, Implantable / adverse effects
Injections, Spinal
Pain Management / methods*
Palliative Care
Pandemics*
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
Practice Guidelines as Topic
SARS-CoV-2
Telemedicine
Triage

Substances

Analgesics, Opioid
Anti-Inflammatory Agents, Non-Steroidal